Minnesota in June approved a 340B contract pharmacy law that forbids drug manufacturers and distributors from limiting access to medications for hospitals and health systems serving uninsured and underinsured populations.
The brief was filed in the U.S. District Court for the District of Minnesota.
Here are four notes:
- Since July 2020, Astrazeneca and 36 other drug companies have begun restricting the 340B discounts for drugs dispensed through community and contract pharmacies. The drugmaker is suing to block Minnesota’s law protecting the discounts.
- The organizations that filed the amicus brief against Astrazeneca are the AHA, 340B Health, the Minnesota Hospital Association and the American Society of Health-System Pharmacists.
- The brief highlighted what the healthcare organizations called “severe financial challenges” faced by Minnesota hospitals, especially those serving rural and underserved communities.
- Azstrazeneca argues that Minnesota’s law conflicts with federal law.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
